{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009684","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.281372+00:00","generated_at":"2026-05-25T01:34:47.631214+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oncocyte promotes James Liu to VP Accounting, Controller, Treasurer; grants RSUs to executives","bullets":["James Liu promoted to VP Accounting, Controller, Treasurer and Principal Accounting Officer, effective March 10, 2025; salary $225,000.","CEO Joshua Riggs annual salary raised to $420,000 from $400,000; CFO Andrea James to $341,250 from $325,000.","One-time RSU grants: CEO $600k (max 200k shares), CFO $360k (max 120k), CSO $360k (max 120k), vesting over 4 years.","CFO Andrea James receives $25,000 one-time bonus in cash or RSUs at her discretion.","James Liu also receives $60k in RSUs (3-year vest) and 10,000 options (4-year vest)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009684","json":"https://secwatch.observer/filing/0001493152-25-009684.json","markdown":"https://secwatch.observer/filing/0001493152-25-009684.md","text":"https://secwatch.observer/filing/0001493152-25-009684.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225009684/0001493152-25-009684-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225009684/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T01:34:47.631214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d71044abce","claim":"James Liu changed role as Vice President Accounting, Controller, Treasurer and Principal Accounting Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"On March 4, 2025, the Company promoted James Liu to Vice President Accounting, Controller, Treasurer and Principal Accounting Officer, effective March 10, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225009684/0001493152-25-009684-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Vice President Accounting, Controller, Treasurer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}